At 7.5% CAGR, Asia Pacific Lithotripsy Market is Projected to be Worth US$ 419.89 Million by 2031, says Business Market Insights

According to Business Market Insights' research, the Asia Pacific lithotripsy market was valued at US$ 235.12 million in 2023 and is expected to reach US$ 419.89 million by 2031, registering a CAGR of 7.5% from 2023 to 2031. Launch of innovative lithotripsy devices and medical reimbursement/coverage for noninvasive lithotripsy procedure are among the critical factors attributed to drive the Asia Pacific lithotripsy market growth.

Several manufacturers are developing technologically advanced products used during lithotripsy to remain competitive in the market across the globe. For example, in January 2022, Olympus announced the launch of its next-generation SOLTIVE Premium SuperPulsed Laser System (SOLTIVE Laser System). The product offers the potential for short procedure time, better patient outcomes, and low procedure cost as compared to standard Holmium: YAG lithotripsy device. Therefore, the launch of innovative lithotripsy devices drives the market.

On the contrary, the rise in product recalls by FDA hampers the growth of Asia Pacific lithotripsy market.

By product type, the Asia Pacific lithotripsy market is segmented into extracorporeal shock wave lithotripsy devices and intracorporeal lithotripsy devices, and ureteroscopic. The extracorporeal shock wave lithotripsy devices segment held 60.0% share of Asia Pacific lithotripsy market share in 2023, amassing US$ 141.10 million. It is projected to garner US$ 269.22 million by 2031 to register 8.4% CAGR during 2023-2031.

In term of application, the Asia Pacific lithotripsy market is segmented into kidney stones, ureteral stones, pancreatic stones, bile duct stones, and bladder stones. The kidney stones segment held 39.9% share of Asia Pacific lithotripsy market share in 2023, amassing US$ 93.82 million. It is projected to garner US$ 177.85 million by 2031 to register 8.3% CAGR during 2023-2031.

Based on end-user, the Asia Pacific lithotripsy market is segmented into hospitals, specialty clinics, and others. The hospitals segment held 73.0% share of Asia Pacific lithotripsy market share in 2023, amassing US$ 171.70 million. It is projected to garner US$ 317.88 million by 2031 to register 8.0% CAGR during 2023-2031.

Based on country, the Asia Pacific lithotripsy market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 31.0% share of Asia Pacific aircraft brackets market in 2023. It was assessed at US$ 72.98 million in 2023 and is likely to hit US$ 139.42 million by 2031, registering a CAGR of 8.4% during 2023-2031.

Key players operating in the Asia Pacific lithotripsy market are Becton Dickinson and Co, Boston Scientific Corp, Cook Medical Holdings LLC, DirexGroup, Dornier MedTech, Edap Tms SA, ELMED Medical Systems, EMS Electro Medical Systems SA (EMS+), Karl Storz SE & Co KG, NOVAmedtk, Olympus Corp, and Potent Medical, among others.

• April-2024: Olympus announced RenaFlex single-use flexible ureteroscope system used to access and visualize the urinary tract to diagnose and treat urinary diseases and disorders such as kidney stones. This new product works in collaboration with combination with the compatible "CV-S1 Video System" for flexible single-use endoscopes.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com